These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 8438454
21. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. Nozaki S, Ito T, Kamiike W, Uchikoshi F, Yamamoto S, Nakata S, Shirakura R, Miyata M, Matsuda H, Stepkowski SM. Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633 [No Abstract] [Full Text] [Related]
22. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients. Nozaki S, Ito T, Kamiike W, Uchikoshi F, Ito A, Kuhara A, Nakata S, Shirakura R, Miyata M, Matsuda H. Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059 [No Abstract] [Full Text] [Related]
23. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. Morris RE, Wu J, Shorthouse R. Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111 [No Abstract] [Full Text] [Related]
24. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW. Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047 [No Abstract] [Full Text] [Related]
25. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats. Hamashima T, Stepkowski SM, Smith S, Kahan BD. Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960 [No Abstract] [Full Text] [Related]
26. The effect of rapamycin on orthotopic small bowel transplantation in the rat. Chen H, Wu J, Xu D, Aboujaoude M, Stepkowski S, Kahan B, Daloze P. Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567 [No Abstract] [Full Text] [Related]
27. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. Transplant Proc; 2005 Jun; 37(1):134-6. PubMed ID: 15808572 [Abstract] [Full Text] [Related]
28. Effect of immunosuppression on chronic rejection in the rat aortic allograft model. Belitsky P, Gulanikar A, He G, Gupta R. Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272 [No Abstract] [Full Text] [Related]
29. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E. Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767 [Abstract] [Full Text] [Related]
30. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression. D'Silva M, DeRoover A, Nishimura Y, Antoniou E, Candinas D, Hubscher SG, McMaster P. Transplant Proc; 1996 Apr 18; 28(2):948-9. PubMed ID: 8623475 [No Abstract] [Full Text] [Related]
31. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation. He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D. Transplant Proc; 1992 Jun 18; 24(3):1178. PubMed ID: 1604577 [No Abstract] [Full Text] [Related]
32. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection. Stepkowski SM, Tian L, Napoli KL, Ghobrial R, Wang ME, Chou TC, Kahan BD. Clin Exp Immunol; 1997 Apr 18; 108(1):63-8. PubMed ID: 9097913 [Abstract] [Full Text] [Related]
33. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion. Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW. Transplantation; 1994 Mar 27; 57(6):933-41. PubMed ID: 8154043 [Abstract] [Full Text] [Related]
34. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Morris RE, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse R, Berry GJ. Transplant Proc; 1995 Jun 27; 27(3):2068-9. PubMed ID: 7792888 [No Abstract] [Full Text] [Related]
35. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y, Waer M. Transplant Proc; 1996 Dec 27; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related]
36. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats. Wang ME, Stepkowski SM, Ferraresso M, Kahan BD. Transplantation; 1992 Oct 27; 54(4):704-9. PubMed ID: 1412762 [Abstract] [Full Text] [Related]
38. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? Deuse T, Schrepfer S, Pelletier MP, Fischbein MP, Robbins RC, Reichenspurner H. Transplant Proc; 2007 Mar 27; 39(2):569-72. PubMed ID: 17362784 [Abstract] [Full Text] [Related]